Protalix BioTherapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -31.97M-29.97M-36.53M-12.17M6.95M3.35M85.32M-0.19M-44.24M-26.99M-18.68M-6.52M-27.58M-14.93M5.22M2.93M
Depreciation and Depletion 0.19M0.31M3.54M3.14M2.37M1.98M1.92M1.70M1.62M1.30M1.12M1.10M1.20M1.30M
Share-based Compensation 2.68M1.28M0.89M7.75M4.09M1.24M1.80M0.99M0.34M0.51M0.83M3.13M2.38M2.08M3.45M3.25M
Deferred Taxes -3.09M0.24M
Cash from Discontinued Operations -6.66M-0.17M1.49M-0.01M
Gains from Sales and Divestitures 0.07M0.17M0.93M0.49M0.99M
Gains from Investment Securities 0.05M0.14M0.17M0.14M0.17M0.14M0.10M0.03M-0.01M-0.03M0.39M1.49M1.79M0.14M0.63M4.14M
Non-cash Items 3,680.38M4,267.85M0.45M0.39M0.53M0.70M0.96M1.73M2.90M1.00M
Cash from Operations 44.45M-38.46M-23.57M0.64M-30.65M-29.28M-25.77M-32.10M-9.99M-7.74M-19.36M-26.11M-10.29M-25.00M-1.32M8.67M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -4.70M-7.59M
Amortization of Deferred Charges 0.13M0.44M0.45M0.57M2.33M2.60M2.99M3.47M2.67M0.30M0.27M
Depreciation & Amortization (CF) 1.99M3.13M3.63M3.69M3.54M3.14M2.37M1.98M1.92M1.70M1.62M1.30M1.12M1.10M1.20M1.30M
Change in Working Capital
Change in Receivables 1.22M6.86M-3.89M-0.24M-2.24M1.01M-0.52M1.13M-0.03M3.10M-0.19M-2.09M1.03M1.19M0.43M-2.32M
Change in Inventory 1.19M-0.91M3.76M3.92M3.45M2.32M-0.52M2.59M0.74M-0.41M4.93M4.87M-1.15M2.24M2.20M
Change in Account Payables 7.78M-1.03M
Change in Accured Expenses 7.78M-1.03M6.15M2.98M0.87M1.37M-1.87M2.14M4.90M-0.76M2.73M2.27M2.38M-4.80M5.29M0.70M
Other Working Capital Changes 64.61M-4.56M-3.00M1.28M-7.16M0.89M0.36M-0.41M24.18M17.88M-9.58M-26.20M13.23M-7.16M-13.18M
Investing Activities
Capital Expenditures 6.20M7.86M5.71M2.07M1.89M0.79M0.46M0.85M0.97M0.69M0.63M0.66M1.46M0.63M1.15M1.28M
Sales of Property, Plant and Equipment 0.07M0.00M0.01M0.00M0.02M0.00M0.05M0.00M
Divestments 39.90M
Change in Acquisitions & Divestments 11.00M5.00M20.42M
Cash from Investing Activities -6.17M-7.99M-5.87M-2.29M-2.10M-1.00M39.39M-0.97M-1.12M-0.59M-0.88M-19.95M18.92M-5.04M-16.71M4.22M
Financing Activities
Cash from Financing Activities 0.29M0.50M20.93M26.56M66.89M0.05M6.63M19.70M-1.42M-4.75M46.47M12.08M8.24M24.67M-16.79M
Additional items
Exchange Rate Effect 0.10M0.59M-0.39M0.13M0.23M-1.40M-0.13M0.28M0.41M-0.27M0.23M0.06M0.01M-0.08M-0.11M0.03M
Change in Cash 38.67M-45.37M-8.90M25.03M34.36M-31.63M21.61M-13.09M-12.12M-13.36M-20.02M0.47M20.72M-21.87M6.52M-3.87M
Beginning Cash Balance 42.60M81.27M35.90M27.00M52.03M86.40M54.77M76.37M63.28M51.16M37.81M17.79M18.27M38.98M17.11M23.63M
Free Cash Flow 38.26M-46.32M-29.27M-1.43M-32.54M-30.07M-26.23M-32.95M-10.96M-8.43M-19.98M-26.76M-11.74M-25.63M-2.47M7.39M
Net Cash Flow 38.57M-45.95M-8.51M24.91M34.14M-30.24M20.25M-13.37M-12.53M-13.09M-20.24M0.41M20.71M-21.80M6.64M-3.90M